United Kingdom · How much has Nuclide Therapeutics raised?
Nuclide Therapeutics has raised $6.7M across 1 round since 2025.
United Kingdom · Seed startup
Who invested in Nuclide Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Nuclide Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$6.7Mraised across 1 round since 2025, from 1 source
- Latest round
- Seed, $6.7MSept 2025
- Investors
- 0
The rounds
- Sept 2025Seed$6.7M
No investor was named in the report.
Source recorded
Funding filed with regulators
Nuclide Therapeutics filed one raise, $3.3M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jul 2025$3.3MUK share allotment
Quick answers about Nuclide Therapeutics
When did Nuclide Therapeutics last raise?
Nuclide Therapeutics's most recent round was a Seed of $6.7M in Sept 2025.
What was Nuclide Therapeutics's biggest round?
Its most recent round, $6.7M in Sept 2025, is also its largest on record.
What stage is Nuclide Therapeutics at?
Nuclide Therapeutics's latest named round is a Seed, in Sept 2025.
Where is Nuclide Therapeutics based?
Nuclide Therapeutics is based in the United Kingdom.
Companies like Nuclide Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.